Tilray Brands (TLRY) Retained Earnings (2017 - 2026)
Tilray Brands (TLRY) posted Retained Earnings of -$44.2 million for Q1 2026, up 99.1% on a QoQ basis from -$4.9 billion in Q4 2025.
Tilray Brands (TLRY) Retained Earnings (2017 - 2026) Analysis & Trends
Tilray Brands' Retained Earnings history runs 10 years deep, the most recent figure standing at -$44.2 million for Q1 2026.
- Quarterly Retained Earnings changed N/A year-over-year to -$44.2 million in Q1 2026, while the trailing twelve-month figure through Feb 2026 was -$44.2 million (changed N/A YoY) and the FY2025 annual result came in at -$43.1 million, up 98.38% from the prior year.
- Retained Earnings was -$44.2 million for Q1 2026 at Tilray Brands, up from -$4.9 billion in the prior quarter.
- Across five years, Retained Earnings topped out at -$20.8 million in Q2 2022 and bottomed at -$4.9 billion in Q4 2025.
- A 5-year average of -$1.5 billion and a median of -$760.5 million in 2022 frame the typical range for Retained Earnings.
- Annual changes were most pronounced in 2024 — Retained Earnings soared 98.4% — and 2025, when it slumped 12056.25%.
- Tilray Brands' Retained Earnings stood at -$121.5 million in 2022, then jumped by 68.41% to -$38.4 million in 2023, then dropped by 25.0% to -$48.0 million in 2024, then plunged by 10101.8% to -$4.9 billion in 2025, then jumped by 99.1% to -$44.2 million in 2026.
- Business Quant data shows TLRY's Retained Earnings at -$44.2 million in Q1 2026, -$4.9 billion in Q4 2025, and -$4.8 billion in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 37.04 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 28.20 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 1.11 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 4.54 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 8.83 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | -1.81 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 18.66 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 589.60 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -2.13 Bn |
| 10 | Tilray Brands | 465.02 Mn | 373.06 Mn | 54.95 Mn | -44.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | -44.20 Mn |
| Nov 30, 2025 | -4.89 Bn |
| Aug 31, 2025 | -4.85 Bn |
| May 31, 2025 | -43.06 Mn |
| Nov 30, 2024 | -47.96 Mn |
| Aug 31, 2024 | -39.88 Mn |
| May 31, 2024 | -2.66 Bn |
| Feb 29, 2024 | -2.63 Bn |
| Nov 30, 2023 | -38.37 Mn |
| Aug 31, 2023 | -2.49 Bn |
| May 31, 2023 | -2.42 Bn |
| Feb 28, 2023 | -2.28 Bn |
| Nov 30, 2022 | -121.46 Mn |
| Aug 31, 2022 | -1.04 Bn |
| May 31, 2022 | -20.76 Mn |
| Feb 28, 2022 | -484.71 Mn |
| Nov 30, 2021 | 9.60 Mn |
| Aug 31, 2021 | 51.25 Mn |
| May 31, 2021 | 152.67 Mn |
| May 31, 2020 | -5.43 Mn |